In order to rule out the differences in activation status between HD and CLL patients as a confounding factor, LDLR levels were also analyzed within the highly activated T-cell population (CD25high) in both groups (gating strategy example in Supplementary Fig. 1H). This evidence concerns the gene LDLR and B-cell chronic lymphocytic leukemia.